title: Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.
authors.affiliation: Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, NY 14642.
authors.forename: M
authors.initials: M
authors.lastname: Weintraub
authors.forename: S
authors.initials: S
authors.lastname: Singh
authors.forename: L
authors.initials: L
authors.lastname: Byrne
authors.forename: K
authors.initials: K
authors.lastname: Maharaj
authors.forename: L
authors.initials: L
authors.lastname: Guttmacher
mesh_terms: D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D011307:Drug Prescriptions; D004358:Drug Therapy; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D007880:Legislation, Drug; D008484:Medicaid; D009518:New York; D011619:Psychotropic Drugs; D014481:United States
chemical_list: D014151:Anti-Anxiety Agents; D011619:Psychotropic Drugs; D001569:Benzodiazepines